Larry Lei Xiao, Ph.D.
Co-Founder,  Chairman, CEO & CSO

Over 20 years of experience in embryonic/induced pluripotent stem cells, cell therapy and gene editing​.

Principal Investigator & Professor at Shanghai Institute of Biochemistry & Cell Biology and at Zhejiang University​.

Postdoctorate at Johns Hopkins.

Ph.D. from Munich University, Germany​.

US based.